Ferozsons Laboratories Limited (PSX:FEROZ)
402.22
+0.37 (0.09%)
At close: Sep 26, 2025
Ferozsons Laboratories Revenue
In the fiscal year ending June 30, 2025, Ferozsons Laboratories had annual revenue of 18.86B PKR with 18.94% growth. Ferozsons Laboratories had revenue of 4.51B in the quarter ending June 30, 2025, with 18.18% growth.
Revenue
18.86B
Revenue Growth
+18.94%
P/S Ratio
0.93
Revenue / Employee
9.95M
Employees
1,896
Market Cap
17.48B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 18.86B | 3.00B | 18.94% |
Jun 30, 2024 | 15.85B | 4.40B | 38.38% |
Jun 30, 2023 | 11.46B | 2.13B | 22.80% |
Jun 30, 2022 | 9.33B | 450.80M | 5.08% |
Jun 30, 2021 | 8.88B | 2.67B | 42.93% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
GlaxoSmithKline Pakistan | 62.62B |
Abbott Laboratories (Pakistan) | 72.39B |
Highnoon Laboratories | 25.78B |
The Searle Company | 29.12B |
AGP Limited | 26.11B |
Shifa International Hospitals | 27.97B |
Citi Pharma | 12.97B |
Macter International | 8.48B |